参考文献/References:
[1] 中华老年骨科与康复电子杂志编辑委员会.股骨头坏死保髋治疗指南(2016版)[J].中华老年骨科与康复电子杂志,2016,2(2):65-70.
[2] CUI L,ZHUANG Q,LIN J,et al.Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China[J].Int Orthop,2016,40(2):267-276.
[3] ZHAO D W,YU M,HU K,et al.Prevalence of Nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[4] ZHANG Q,YANG F,CHEN Y,et al.Chinese herbal medicine formulas as adjuvant therapy for osteonecrosis of the femoral head:a systematic review and meta-analysis of randomized controlled trials [J].Medicine(Baltimore),2018,97(36):e12196.
[5] 陈雷雷,何伟,张庆文,等.中医药治疗股骨头坏死临床试验的系统评价[J].中华中医药杂志,2012,27(3):710-715.
[6] 杨公博,朱立国,何佩珊,等.中药补肾活血汤治疗老年肾虚型腰椎间盘突出症的临床研究[J].中华中医药杂志,2017,32(2):604-606.
[7] 何伟,陈镇秋,张庆文.补肾活血中药治疗股骨头坏死临床研究[J].新中医,2012,44(4):50-51.
[8] 帅波,沈霖,杨艳萍,等.补肾活血方治疗早期缺血性股骨头坏死患者的临床研究[J].中国中医骨伤科杂志,2013,21(1):11-14.
[9] 张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(3):20-23.
[10] 姚晨,沈计荣,杜斌,等.口服补肾活血汤联合微创保髋术治疗股骨头坏死肾虚血瘀证的临床研究[J].中医正骨,2016,28(11):7-12.
[11] 夏天卫,刘金柱,施乐,等.补肾活血汤治疗早期股骨头坏死的症状转归及作用机制分析[J].中外医学研究,2019,17(22):47-49.
[12] 魏伟,沈计荣,姚晨,等.旋转截骨术配合口服补肾活血汤治疗中青年ARCO Ⅲ期股骨头骨坏死的近期疗效[J].世界中医药,2019,14(4):936-940.
[13] 李业清.髋关节外科脱位死骨清理打压植骨联合补肾活血汤治疗股骨头坏死ARCOⅢ_A~Ⅲ_B期临床研究[D].南京:南京中医药大学,2017.
[14] 许芝俊.打压植骨术联合补肾活血汤治疗股骨头坏死的临床研究[D].南京:南京中医药大学,2016.
[15] 刘志华,孙晓波.网络药理学:中医药现代化的新机遇[J].药学学报,2012,47(6):696-703.
[16] LIU C X,LIU R,FAN H R,et al.Network pharmacology bridges traditional applicatio n and modern development of traditional Chinese medicine[J].Chin Herb Med,2015,7(1):3-17.
[17] 谢盈彧,刘璐,李渊芳,等.基于网络药理学的四妙勇安汤在血管新生中的作用机制研究[J].中草药,2018,49(18):4319-4330.
[18] 刘艳飞,孙明月,赵莹科,等.网络药理学在中药药物重定位研究中的应用现状与思考[J].中国循证医学杂志,2017,17(11):1344-1349.
[19] 王琳珊,靳会欣,董占军.系统药理学研究方法在中药不良反应研究中的应用进展[J].中国药房,2017,28(35):5033-5036.
[20] MUTHUKURU M,DARVEAU R P.TLR signaling that induces weak inflammatory response and SHIP1 enhances osteogenic functions[J].Bone Res,2014,2(4):218-230.
[21] HUANG R L,YUAN Y,ZOU G M,et al.LPS-stimulated inflammatory environment inhibits BMP-2-induced osteoblastic differentiation through crosstalk between TLR4/MyD88/NF-κB and BMP/Smad signaling[J].Stem Cells Dev,2014,23(3):277-289.
[22] PEI J,FAN L,NAN K,et al.Excessive activation of TLR4/NF-κB interactively suppresses the canonical Wnt/β-catenin pathway and induces SANFH in SD rats[J].Sci Rep,2017,7(1):11928.
[23] TIAN L,ZHOU D,WANG K,et al.Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats[J].J Huazhong Univ Sci Technolog Med Sci,2014,34(5):679-686.
[24] WEINSTEIN R S,JILKA R L,ALMEIDA M,et al.Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability,bone formation,and strength in mice[J].Endocrinology,2010,151(6):2641-2649.
[25] TIANWEI XIA,JIRONG SHEN,RUNZI GAO,et al.Trans-cinnamaldehyde inhibits IL-1β-stimulated inflammation in chondrocytes by suppressing NF-κB and p38-JNK pathways and exerts chondrocyte protective effects in a rat model of osteoarthritis[J].Biomed Res Int,2019[2020-01-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530235/.
[26] HAN Y,JUNG H W,LEE J Y,et al.2,5-dihydroxyacetophenone isolated from rehmanniae radix preparata inhibits inflammatory responses in lipopolysaccharide-stimulated RAW264.7 macrophages[J].J Med Food,2012,15(6):505-510.
[27] WANG C,PENG J,LU S.Summary of the various treatments for osteonecrosis of the femoral head by mechanism:a review[J].Exp Ther Med,2014,8(3):700-706.
[28] WEI LI,ZILIANG YE,WEI WANG,et al.Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis:a systematic review and meta-analysis[J].Orthopade,2016,46(5):440-446.
[29] TROUSDALE R T.Femoral Head resurfacing for the treatment of osteonecrosis in the young patient[J].Clin Orthop Relat Res,2004,425(417):290-291.
[30] GALE N W,YANCOPOULOS G D.Growth factors acting via endothelial cell-specific receptor tyrosine kinases:VEGFs,angiopoietins,and ephrins in vascular development[J].Genes Dev,1999,3(9):1055-1066.
[31] CHEN Y,MATHY N W,LU H.The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non?small cell lung cancer(Review)[J].Mol Med Rep,2018,17(6):8019-8030.
[32] LI W,SAKAI T,NISHII T,et al.Distribution of TRAP-positive cells and expression of HIF-1alpha,VEGF,and FGF-2 in the reparative reaction in patients with osteonecrosis of the femoral head[J].J Orthop Res,2009,27(5):694-700.
[33] HONG G J,LIN N,CHEN L L,et al.Association between vascular endothelial growth factor gene polymorphisms and the risk of osteonecrosis of the femoral head:systematic review[J].Biomed Rep,2016,4(1):92-96.
[34] HANG D,WANG Q,GUO C,et al.Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs[J].Cells Tissues Organs,2012,195(6):495-506.
[35] GAO Y S,WANG H F,DING H,et al.A novel rat model of osteonecrosis of the femoral head induced by periarticular injection of vascular endothelial growth factor receptor 2 antibody[J].J Surg Res,2013,183(1):e1-e5.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]唐立明,庞智晖,樊粤光,等.“辨稳论治”微观辨证理念指导下的股骨头坏死围塌陷期分型及其临床应用价值[J].中医正骨,2016,28(05):63.
[11]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):20.
[12]姚晨,沈计荣,杜斌,等.口服补肾活血汤联合微创保髋术治疗股骨头坏死肾虚血瘀证的临床研究[J].中医正骨,2016,28(11):7.
YAO Chen,SHEN Jirong,DU Bin,et al.Clinical study on oral application of Bushen Huoxue Tang(补肾活血汤)combined with minimally invasive hip-preserving surgery for treatment of kidney-deficiency-blood-stasis-type osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):7.
[13]范奕松,俞桂松,唐振坤,等.补肾活血汤治疗股骨头坏死的系统评价[J].中医正骨,2020,32(03):26.
FAN Yisong,YU Guisong,TANG Zhenkun,et al.Systematic review on Bushen Huoxue Tang(补肾活血汤)for treatment of osteonecrosis of the femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(03):26.